*with or without dextrose fermentation
References:
1. Williams, O.B., (1936). Food Res.1,217.
2. Cameron, E.J., (1936). J. Assoc. Official Agr.
Chem. 19, 433
3. American Type Culture Collection
inhibitor for Gram-nega-
tive bacteria was reported in the studies of EDWARDS (1933,
1938) and HARTMANN (1936) on the isolation of Str. agalactiae.
MALLMANN (1940) and SNYDER and LICHSTEIN (1940) later
showed
Biochemistry,
20(11), 3076-3083 (1981).
2. Sumner, J.B. and Howell, S.F., J. Biol. Chem.,
115, 583 (1936).
3. Olson, M.O. and Liener, I.E., Some physical and
chemical properties of concanavalin A, the
O. Voges, B. Proskauer, Z. f. Hyg., 28, 20-22 (1898)
4. M.M. Barritt, J. Path. Bact. 42, 441-454 (1936)
5. R.A.Q. O'Meara, J. Path. Bact., 34, 401 (1931)
6. International Organization for Standardization
under argon or nitrogen at 2-8°C may be
preferred.
References
1. Supplier data (Triton X-100 is a product of Union
Carbide.)
2. Wexler, A.S., Anal. Chem., 35, 1936-1943 (1963).
3. Sigma data.
Biochemistry,
20(11), 3076-3083 (1981).
2. Sumner, J.B. and Howell, S.F., J. Biol. Chem., 115,
583 (1936).
3. Olson, M.O. and Liener, I.E., Some physical and
chemical properties of concanavalin A, the
Germany), p. 572 (1993).
21. Kunitz, M., and Northrop, J.H., J. Gen. Physiol.,
19(6), 991-1007 (1936).
22. Sherman, M.P., and Kassell, B., Biochemistry,
7(10), 3634-3641 (1968).
23. Zyznar
Germany), p. 572 (1993).
21. Kunitz, M., and Northrop, J.H., J. Gen. Physiol.,
19(6), 991-1007 (1936).
22. Sherman, M.P., and Kassell, B., Biochemistry,
7(10), 3634-3641 (1968).
23. Zyznar
vaccine (EU) and
Cervarix® vaccine (EU, US 2009)
contain alum and AS04,
a MPL adjuvant.
1936–1937
Adjuvant properties of
Quil A and emulsions discovered.
1997
Fluad® vaccine contains
Albericio (2013) Org. Lett., 15, 616.
8. M. Gongora-Benitez, et al. (2012) Org. Lett., 14, 5472.
9. H. Hibino, et al. (2014) J. Pept. Sci., 20, 30.
10. C. V. Smythe (1936) J. Biol. Chem., 114, 601
11
Each
1.2 ml, green
individually wrapped
M 1936 781270 384-well storage plate, 60 Each
240 µl/well, clear, conical bottom
O
r
d
e
r
:
1
.
8
0
0
.
3
2
5
.
3
0
1
0
recombinant
osteoprotegerin therapy in Lewis rats with adjuvant arthritis. Arthritis & Rheumatism
46:1926-1936 (2002)
Croucher PI, Shipman CM, Lippitt J, perry M, Asosingh K, Hijzen A, Brabbs AC, Beek E,
Holen
& Unit
Production Flow Rate 8 l/hour (Milli-Q® Direct 8)
16 l/ hour (Milli-Q® Direct 16)
Delivery Flow rate From tap:
up to 2.5 l/min
From optional pump:
up to 15 l/min at 1 bar
Type 1 Product